AETHLON MEDICAL INC 8-K

What Happened

• Aethlon Medical Inc. filed a Form 8-K on February 12, 2026 disclosing results of operations and financial condition under Item 2.02. The company also furnished a Regulation FD press release dated February 12, 2026, which it attached as Exhibit 99.1 to the filing. The Regulation FD disclosure is incorporated by reference into the Form 8-K.

Key Details

• Filing date: February 12, 2026 (Form 8-K).
• Item 2.02: Results of Operations and Financial Condition were reported (details provided in the furnished press release).
• Item 7.01: Regulation FD Disclosure — a press release dated February 12, 2026 was furnished as Exhibit 99.1.
• Item 9.01 Exhibits included Exhibit 99.1 (press release) and Exhibit 104 (interactive XBRL cover page).

Why It Matters

• The company has publicly updated investors about its recent financial results and condition; the press release contains the specific financial figures and narrative investors should review. Because the disclosure was furnished under Regulation FD, the information was broadly released to the market to ensure fair access. Retail investors should read Exhibit 99.1 (the Feb 12, 2026 press release) or the full 8-K on the SEC site to see the detailed numbers and decide whether the new information affects their investment thesis.